Related Experiment Video
Updated: Oct 27, 2025

05:06
Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
Published on: May 5, 2020
13.7K
Protocol for Morphological and Functional Phenotype Analysis of hiPS-Derived Cardiomyocytes
1Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Methods in Molecular Biology (Clifton, N.J.)
|July 24, 2021
Summary
Induced pluripotent stem cells (iPSCs) are valuable for studying heart development and disease. Comprehensive evaluation protocols for iPS-derived cardiomyocytes and tissues are essential for advancing cardiac research.
Area of Science:
- Cardiovascular Biology
- Stem Cell Research
- Regenerative Medicine
Background:
- Induced pluripotent stem cells (iPSCs) offer a powerful tool for modeling human physiological development and disease.
- iPSC-derived cardiomyocytes and engineered cardiac tissues are increasingly used in cardiac research.
- Current research highlights the need for robust evaluation methods for these cells and tissues.
Purpose of the Study:
- To emphasize the indispensable need for comprehensive evaluation protocols for iPSC-derived cells and tissues.
- To underscore the importance of these protocols in advancing cardiac development and disease modeling.
- To highlight the potential of iPSCs in understanding heart disease pathogenesis.
Main Methods:
- Review of existing protocols for cardiac differentiation and 3D cardiac tissue construction.
- Identification of gaps in current evaluation methodologies for iPSC-derived cardiac models.
- Discussion on the requirements for comprehensive physiological and pathophysiological assessments.
Main Results:
- Protocols for cardiac differentiation and 3D tissue engineering are established.
- There is a critical need for standardized and comprehensive evaluation protocols.
- Existing evaluation methods may not fully capture the complex properties of iPS-derived cardiac cells/tissues.
Conclusions:
- Establishing comprehensive evaluation protocols is crucial for the effective utilization of iPSCs in cardiac research.
- These protocols will enhance the reliability of iPSC-based disease modeling and drug screening.
- Advancements in evaluation methods are essential for translating iPSC technology to clinical applications.

